DE69116874D1 - Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen - Google Patents

Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen

Info

Publication number
DE69116874D1
DE69116874D1 DE69116874T DE69116874T DE69116874D1 DE 69116874 D1 DE69116874 D1 DE 69116874D1 DE 69116874 T DE69116874 T DE 69116874T DE 69116874 T DE69116874 T DE 69116874T DE 69116874 D1 DE69116874 D1 DE 69116874D1
Authority
DE
Germany
Prior art keywords
pct
immunogenic peptide
diagnostic
therapeutic use
encoding dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69116874T
Other languages
English (en)
Inventor
Brigitte Facon
Mustapha Chamekh
Colette Dissous
Andre Capron
Andre Tartar
Masse Helene Gras
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE69116874D1 publication Critical patent/DE69116874D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4355—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69116874T 1990-07-12 1991-07-11 Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen Expired - Lifetime DE69116874D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9008900A FR2664613B1 (fr) 1990-07-12 1990-07-12 Sequence peptidique immunogene d'echinococcus granulosus, sequence d'adn codant pour cette sequence peptidique et applications diagnostiques et therapeutiques.
PCT/FR1991/000563 WO1992001051A1 (fr) 1990-07-12 1991-07-11 Sequence peptidique immunogene d'echinococcus granulosus, sequence d'adn codant pour cette sequence peptidique et applications diagnostiques et therapeutiques

Publications (1)

Publication Number Publication Date
DE69116874D1 true DE69116874D1 (de) 1996-03-14

Family

ID=9398651

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69116874T Expired - Lifetime DE69116874D1 (de) 1990-07-12 1991-07-11 Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen

Country Status (8)

Country Link
US (1) US5541078A (de)
EP (1) EP0538352B1 (de)
JP (1) JPH06500992A (de)
AT (1) ATE133708T1 (de)
CA (1) CA2087005A1 (de)
DE (1) DE69116874D1 (de)
FR (1) FR2664613B1 (de)
WO (1) WO1992001051A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664613B1 (fr) * 1990-07-12 1994-08-26 Pasteur Institut Sequence peptidique immunogene d'echinococcus granulosus, sequence d'adn codant pour cette sequence peptidique et applications diagnostiques et therapeutiques.
AU676828B2 (en) * 1992-02-21 1997-03-27 New Zealand Pastoral Agriculture Research Institute Limited Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens
IT1271437B (it) * 1993-03-12 1997-05-28 Lofarma Farma Lab Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
AUPS238502A0 (en) * 2002-05-17 2002-06-13 Council Of The Queensland Institute Of Medical Research, The Cystic echinococcosis protein and uses therefor
CN110261615B (zh) * 2019-07-04 2021-10-15 中国动物疫病预防控制中心(农业农村部屠宰技术中心) 囊型包虫病诊断试剂盒及其应用
CN110845569A (zh) * 2019-11-15 2020-02-28 石河子大学 一种从细粒棘球蚴中提取总蛋白的方法
CN110954690B (zh) * 2019-12-30 2023-09-19 北京明日达科技发展有限责任公司 一种检测羊包虫病elisa抗体检测试剂盒及其应用
CN111269890B (zh) * 2020-03-25 2023-07-04 新疆畜牧科学院兽医研究所（新疆畜牧科学院动物临床医学研究中心） 抗包虫病抗原单克隆抗体杂交瘤细胞株和抗包虫病抗原单克隆抗体及其应用
CN112611872A (zh) * 2020-12-30 2021-04-06 新疆畜牧科学院兽医研究所（新疆畜牧科学院动物临床医学研究中心） 一种犬细粒棘球绦虫抗原双抗夹心elisa检测试剂盒及其制备方法和应用
CN113372452B (zh) * 2021-06-08 2022-11-29 新疆医科大学 一种细粒棘球绦虫重组蛋白CTLA4-IgV-EgG1Y162及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664613B1 (fr) * 1990-07-12 1994-08-26 Pasteur Institut Sequence peptidique immunogene d'echinococcus granulosus, sequence d'adn codant pour cette sequence peptidique et applications diagnostiques et therapeutiques.

Also Published As

Publication number Publication date
EP0538352A1 (de) 1993-04-28
CA2087005A1 (fr) 1992-01-13
US5541078A (en) 1996-07-30
EP0538352B1 (de) 1996-01-31
WO1992001051A1 (fr) 1992-01-23
FR2664613A1 (fr) 1992-01-17
ATE133708T1 (de) 1996-02-15
JPH06500992A (ja) 1994-01-27
FR2664613B1 (fr) 1994-08-26

Similar Documents

Publication Publication Date Title
ATE178907T1 (de) Rezeptorbindende region des diphtherietoxius
ATE355074T1 (de) Hybrid aus interferon-alpha und immunglobulin fc- fragment verbunden durch ein nicht immunogenes peptid
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
HK1115607A1 (en) Human cytokine receptor
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ATE194291T1 (de) Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
DE69116874D1 (de) Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen
DE69306803D1 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
NO975565L (no) Benstimulerende faktor
US20040005321A1 (en) Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotheraphy
DE69420970D1 (de) Impfstoff zubereitungen
DK0472706T3 (da) Induktion af beskyttelse mod viral infektion
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
ELEcT AD-A243 278 AD
Chanh et al. Immunological approach to the identification and development of vaccines to various toxins.
Kraaijeveld et al. Detection of a shared idiotope on two encephalomyocarditis virus neutralizing monoclonal antibodies by neutralization inhibition enzyme immunoassay
SE9304291D0 (sv) A diagnostic antigen and a method of in vitro diagnosing an active infection caused by hepatitis C virus
RU93004854A (ru) Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека
DK200401498A (da) Human vævsfaktor-relaterede DNA-segmenter, polypeptider og antistoffer

Legal Events

Date Code Title Description
8332 No legal effect for de